Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

Drug repurposing can create safer, cheaper treatments by finding new uses for existing drugs.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Scientists created a lab-grown hair follicle model that behaves like real hair and could improve hair loss treatment research.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

The method effectively detects banned substances in urine for sports antidoping.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The developed system could effectively treat hair loss and promote hair growth.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

HIV-positive patients, especially men who have sex with men, had a high rate of skin diseases and sexually transmitted infections.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Certain genetic markers may increase or decrease prostate cancer risk.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Efficient PCOS screening is crucial for early detection, with lifestyle factors like fruit intake potentially aiding prevention.